Catalyst Pharmaceutical Partners Inc buy Citigroup Inc.
Start price
07.11.25
/
50%
€18.50
Target price
07.11.26
€28.60
Performance (%)
9.87%
Price
12.03.26
€20.32
Summary
This prediction is currently active. The BUY prediction by Citigroup_Inc_ shows slight gains of 9.87%. This prediction currently runs until 07.11.26. The prediction end date can be changed by Citigroup_Inc_ at any time. Citigroup_Inc_ has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Catalyst Pharmaceutical Partners Inc | -3.007% | -3.007% |
| iShares Core DAX® | -1,34 % | -5,62 % |
| iShares Nasdaq 100 | -1,07 % | 2,60 % |
| iShares Nikkei 225® | -1,99 % | -6,51 % |
| iShares S&P 500 | -1,32 % | 0,91 % |
Comments by Citigroup_Inc_ for this prediction
In the thread Catalyst Pharmaceutical Partners Inc diskutieren
Catalyst Pharmaceuticals (NASDAQ:CPRX) had its price target raised by analysts at Citigroup Inc. from $31.00 to $33.00. They now have a "buy" rating on the stock.
Ratings data for CPRX provided by MarketBeat
Stopped prediction by Citigroup_Inc_ for Catalyst Pharmaceutical Partners Inc
Catalyst Pharmaceutical Partners Inc
Start price
Target price
Perf. (%)
€20.55
03.03.26
03.03.26
€29.92
03.03.27
03.03.27
-1.12%
12.03.26
12.03.26
Catalyst Pharmaceutical Partners Inc
Start price
Target price
Perf. (%)
€15.01
14.03.24
14.03.24
€24.74
14.03.25
14.03.25
26.78%
15.03.25
15.03.25